Praise for IABS Biotherapeutics Committee Chair Tony Mire-Sluis

 

Dear Colleagues,

 

Please join me in acknowledging and thanking Anthony (Tony) Mire-Sluis for his remarkable management of the IABS Biotherapeutics Committee since 2010.  After serving in this role for the past seven years, Tony is rotating out of the Chair position. 

While his Committee aided IABS in many ways, one of the most significant accomplishments was the successful collaboration with the US Food and Drug Administration on four FDA/IABS annual workshops on Statistical and Data Management Approaches for Biotechnology Drug Development.   These workshops elevated the value of statistics in Chemistry, Manufacturing, and Controls (CMC) development and lifecycle management and brought FDA and industry statisticians and nonstatisticians together to discuss strategies and methods for addressing significant challenges in ensuring the quality of biotechnological and vaccines products.  Thank you, Tony, for all of your hard work as Committee Chair

 

Joris Vandeputte, President IABS

 

International Alliance for Biological Standardization


Twitter Feed

Developing a global #haplobank system for clinical-grade induced #pluripotent #stemcells.… https://t.co/H65UxrvHmK
#IABS #CIRM #CellTherapy Characterization of #CARTcells-#autologous vs #allogeneic. https://t.co/rUoWk79kIA
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.